Repurposing of the Tamoxifen Metabolites to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli

The development of new strategic antimicrobial therapeutic approaches, such as drug repurposing, has become an urgent need. Previously, we reported that tamoxifen presents therapeutic efficacy against multidrug-resistant (MDR) Acinetobacter baumannii, Pseudomonas aeruginosa, and Escherichia coli in...

Descripción completa

Detalles Bibliográficos
Autores principales: Miró-Canturri, Andrea, Ayerbe-Algaba, Rafael, Vila-Domínguez, Andrea, Jiménez-Mejías, Manuel E., Pachón, Jerónimo, Smani, Younes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004611/
https://www.ncbi.nlm.nih.gov/pubmed/33810067
http://dx.doi.org/10.3390/antibiotics10030336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004611/
https://www.ncbi.nlm.nih.gov/pubmed/33810067
http://dx.doi.org/10.3390/antibiotics10030336

Ejemplares similares